TTM
$21B
YoY change
+19.9%
5Y CAGR
+15.2%
Peak year (FY2025)
$20.1B
Cumulative revenue
$246B
Revenue history chart for Boston Scientific (BSX) from 2016 to 2025
Latest: $20.1B
Revenue growth chart for Boston Scientific (BSX) from 2016 to 2025
Latest: +19.9%
Revenue history table for Boston Scientific (BSX) from 1991 to 2025
| FY2025 | $20.1B | +19.9% | +$3.33B | ||
| FY2024 | $16.7B | +17.6% | +$2.51B | ||
| FY2023 | $14.2B | +12.3% | +$1.56B | ||
| FY2022 | $12.7B | +6.7% | +$794M | ||
| FY2021 | $11.9B | +19.9% | +$1.98B | ||
| FY2020 | $9.91B | -7.7% | -$822M | ||
| FY2019 | $10.7B | +9.3% | +$912M | ||
| FY2018 | $9.82B | +8.6% | +$775M | ||
| FY2017 | $9.05B | +7.9% | +$662M | ||
| FY2016 | $8.39B | +12.2% | +$909M | ||
| FY2015 | $7.48B | +1.3% | +$97M | ||
| FY2014 | $7.38B | +3.3% | +$237M | ||
| FY2013 | $7.14B | -1.5% | -$106M | ||
| FY2012 | $7.25B | -4.9% | -$373M | ||
| FY2011 | $7.62B | -2.4% | -$184M | ||
| FY2010 | $7.81B | -4.7% | -$382M | ||
| FY2009 | $8.19B | +1.7% | +$138M | ||
| FY2008 | $8.05B | -3.7% | -$307M | ||
| FY2007 | $8.36B | +6.9% | +$536M | ||
| FY2006 | $7.82B | +24.5% | +$1.54B | ||
| FY2005 | $6.28B | +11.7% | +$659M | ||
| FY2004 | $5.62B | +61.8% | +$2.15B | ||
| FY2003 | $3.48B | +19.1% | +$557M | ||
| FY2002 | $2.92B | +9.2% | +$246M | ||
| FY2001 | $2.67B | +0.3% | +$9M | ||
| FY2000 | $2.66B | -6.3% | -$178M | ||
| FY1999 | $2.84B | +27.2% | +$608M | ||
| FY1998 | $2.23B | +19.3% | +$361M | ||
| FY1997 | $1.87B | +28.1% | +$410M | ||
| FY1996 | $1.46B | +32.1% | +$355M | ||
| FY1995 | $1.11B | +146.6% | +$658M | ||
| FY1994 | $449M | +18.1% | +$68.8M | ||
| FY1993 | $380M | +20.6% | +$64.9M | ||
| FY1992 | $315M | +37.0% | +$85.2M | ||
| FY1991 | $230M | — | — |
- FY2025$20.1B+19.9%
- FY2024$16.7B+17.6%
- FY2023$14.2B+12.3%
- FY2022$12.7B+6.7%
- FY2021$11.9B+19.9%
- FY2020$9.91B-7.7%
- FY2019$10.7B+9.3%
- FY2018$9.82B+8.6%
- FY2017$9.05B+7.9%
- FY2016$8.39B+12.2%
- FY2015$7.48B+1.3%
- FY2014$7.38B+3.3%
- FY2013$7.14B-1.5%
- FY2012$7.25B-4.9%
- FY2011$7.62B-2.4%
- FY2010$7.81B-4.7%
- FY2009$8.19B+1.7%
- FY2008$8.05B-3.7%
- FY2007$8.36B+6.9%
- FY2006$7.82B+24.5%
- FY2005$6.28B+11.7%
- FY2004$5.62B+61.8%
- FY2003$3.48B+19.1%
- FY2002$2.92B+9.2%
- FY2001$2.67B+0.3%
- FY2000$2.66B-6.3%
- FY1999$2.84B+27.2%
- FY1998$2.23B+19.3%
- FY1997$1.87B+28.1%
- FY1996$1.46B+32.1%
- FY1995$1.11B+146.6%
- FY1994$449M+18.1%
- FY1993$380M+20.6%
- FY1992$315M+37.0%
- FY1991$230M—
Revenue values are taken from Boston Scientific's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Revenue at Boston Scientific (BSX)
According to Boston Scientific's latest reported financial statements, the company's current revenue (TTM) is $21B. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Boston Scientific (BSX) revenue is $20.1B – grew 19.9% year-over-year.
Boston Scientific revenue has grown for 5 consecutive years, with a +15.2% compound annual growth rate over 2020–2025 (5 years).
The highest annual revenue of $20.1B was reported in 2025. The lowest in the available history was $230M in 1991.
Boston Scientific Revenue by Year
Boston Scientific Revenue 2025: $20.1B
In 2025, Boston Scientific reported revenue of $20.1B, grew 19.9% from 2024. This figure represents the highest annual value in the available history.
Boston Scientific Revenue 2024: $16.7B
Boston Scientific revenue in 2024 was $16.7B, grew 17.6% from 2023.
Boston Scientific Revenue 2023: $14.2B
2023's revenue for Boston Scientific came in at $14.2B, grew 12.3% from 2022.
Boston Scientific Revenue 2022: $12.7B
Boston Scientific posted revenue of $12.7B in 2022, grew 6.7% from 2021.
Boston Scientific Revenue 2021: $11.9B
Boston Scientific revenue in 2021 was $11.9B.
See more financial history for Boston Scientific (BSX).
Sector peers by Revenue
Healthcare peers of Boston Scientific (BSX), ranked by their latest revenue
| $448B | |
| $94.2B | |
| $65.2B | |
| $64.9B | |
| $61.2B | |
| $48.2B | |
| $44.6B | |
| $36.7B |
- $94.2B
- $65.2B
- $64.9B
- $61.2B
- $48.2B
- $36.7B
Frequently asked questions
Boston Scientific (BSX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.